Intranasal Delivery of PEGylated Mesoporous Silica Nanoparticles for Enhanced Brain Targeting: In Vivo Evaluation of Pharmacokinetics, Biodistribution and Biocompatibility
Engineered Science · 2026
DOI: 10.30919/es2173 ↗Kurz gefasst
Fachartikel in der Zeitschrift Engineered Science, 2026. Verfasst von Reem Darwesh, und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Darwesh,, R., Sofi, B. F., Elbialy, N. S., & Alsalah, J. H. (2026). Intranasal Delivery of PEGylated Mesoporous Silica Nanoparticles for Enhanced Brain Targeting: In Vivo Evaluation of Pharmacokinetics, Biodistribution and Biocompatibility. Engineered Science. https://doi.org/10.30919/es2173
Vancouver
Darwesh, R, Sofi BF, Elbialy NS, Alsalah JH. Intranasal Delivery of PEGylated Mesoporous Silica Nanoparticles for Enhanced Brain Targeting: In Vivo Evaluation of Pharmacokinetics, Biodistribution and Biocompatibility. Engineered Science. 2026. doi:10.30919/es2173
BibTeX
@article{Darwesh2026,
author = {Darwesh,, Reem and Sofi, Balsam Fahad and Elbialy, Nihal S. and Alsalah, Jaber Hussain},
title = {Intranasal Delivery of PEGylated Mesoporous Silica Nanoparticles for Enhanced Brain Targeting: In Vivo Evaluation of Pharmacokinetics, Biodistribution and Biocompatibility},
journal = {Engineered Science},
year = {2026},
doi = {10.30919/es2173}
}
EUVIMED